Loading...

Lonza Group AG

LZAGYPNK
HealthcareMedical - Diagnostics & Research
$69.29
$1.20(1.75%)

Lonza Group AG LZAGY Peers

See (LZAGY) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LZAGY$69.29+1.75%50B63.57$1.09+0.74%
LZAGF$689.88-2.51%48.5B63.52$10.86+0.42%
WUXAY$8.74-1.91%24.2B16.19$0.54+0.74%
WUXIF$7.34N/A21B13.59$0.54+2.54%
BMXMF$134.25+1.18%15.8B32.43$4.14+0.69%
ERFSF$66.99+4.62%11.8B28.15$2.38+1.60%
SKHCF$18.10N/A8.7B24.79$0.73+3.88%
SKHHY$17.21+0.76%8.3B23.26$0.74+3.92%
DSRLF$92.31-15.31%5B23.43$3.94+1.47%
HNGZY$4.00N/A4.5B26.67$0.15+1.99%
Showing 1 to 10 of 79 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LZAGY vs LZAGF Comparison

LZAGY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LZAGY stands at 50B. In comparison, LZAGF has a market cap of 48.5B. Regarding current trading prices, LZAGY is priced at $69.29, while LZAGF trades at $689.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LZAGY currently has a P/E ratio of 63.57, whereas LZAGF's P/E ratio is 63.52. In terms of profitability, LZAGY's ROE is +0.06%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, LZAGY is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for LZAGY.

Stock Price Comparison

Loading...

Frequently Asked Questions